Sulphadoxine/Pyrimethamine

also known as Fansidar

Developed for: malaria
Investigated by: London School of Hygiene and Tropical Medicine · University of Yaounde

today NCT00146718 · Ph 2/3

2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 2/3	NCT00146718	Aug 2003 → May 2005	malaria	London School of Hygiene and Tropical Medicine	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	sulphadoxine-pyrimethamine	“sulphadoxine-pyrimethamine(SP)” NCT00146718 ↗ 1 NCT00146718 ↗
Known as	Fansidar	“Fansidar(SP)” NCT00146718 ↗